Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021 March 6, 2026
Patient Out‐of‐Pocket Costs Following the Availability of Biosimilar Versions of Infliximab March 6, 2026
Frequency of Approval and Marketing of Biosimilars with a Skinny Label and Associated Medicare Savings March 6, 2026
Therapeutic Value of Drugs Frequently Marketed Using Direct-To-Consumer Television Advertising, 2015 to 2021 March 6, 2026
Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-Name Drugs Incorporating Best Price Rebates, 2015 to 2019 March 6, 2026
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021 March 6, 2026